Abhimanyu Roy, Executive Director at Avalon Consulting, shared his perspectives with BioSpectrum Ltd India on how strategic acquisitions are shaping the next phase of India’s life sciences and healthcare startups.
He highlighted that companies increasingly use acquisitions to build integrated healthcare platforms, fill gaps across the patient journey, and expand customer share of wallet. As healthcare becomes more digital, technology and AI capabilities are also expected to drive future M&A activity.
